GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » Book Value per Share

Spago Nanomedical AB (OSTO:SPAGO) Book Value per Share : kr0.10 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB Book Value per Share?

Spago Nanomedical AB's book value per share for the quarter that ended in Dec. 2024 was kr0.10.

During the past 12 months, Spago Nanomedical AB's average Book Value Per Share Growth Rate was -56.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -71.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -58.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -30.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Spago Nanomedical AB was -2.70% per year. The lowest was -71.80% per year. And the median was -10.90% per year.

Spago Nanomedical AB's current price is kr0.181. Its book value per share for the quarter that ended in Dec. 2024 was kr0.10. Hence, today's PB Ratio of Spago Nanomedical AB is 1.91.

During the past 13 years, the highest P/B Ratio of Spago Nanomedical AB was 2.91. The lowest was 0.14. And the median was 1.48.


Spago Nanomedical AB Book Value per Share Historical Data

The historical data trend for Spago Nanomedical AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Book Value per Share Chart

Spago Nanomedical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.74 4.23 2.07 0.22 0.10

Spago Nanomedical AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.15 0.14 0.12 0.10

Competitive Comparison of Spago Nanomedical AB's Book Value per Share

For the Biotechnology subindustry, Spago Nanomedical AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's PB Ratio falls into.


;
;

Spago Nanomedical AB Book Value per Share Calculation

Spago Nanomedical AB's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(33.24-0.00)/348.20
=0.10

Spago Nanomedical AB's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(33.24-0.00)/348.20
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Spago Nanomedical AB  (OSTO:SPAGO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Spago Nanomedical AB Book Value per Share Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB Headlines

No Headlines